Search Results

There are 4369 results for: content related to: Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth

  1. Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 4, April 2012, Pages: 673–684, E D Kharasch, D Whittington, D Ensign, C Hoffer, P S Bedynek, S Campbell, K Stubbert, A Crafford, A London and T Kim

    Article first published online : 7 MAR 2012, DOI: 10.1038/clpt.2011.276

  2. Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 676–684, E Ngaimisi, S Mugusi, O M Minzi, P Sasi, K-D Riedel, A Suda, N Ueda, M Janabi, F Mugusi, W E Haefeli, J Burhenne and E Aklillu

    Article first published online : 29 SEP 2010, DOI: 10.1038/clpt.2010.172

  3. You have free access to this content
    Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa

    British Journal of Clinical Pharmacology

    Volume 80, Issue 1, July 2015, Pages: 146–156, Phumla Z. Sinxadi, Paul D. Leger, Helen M. McIlleron, Peter J. Smith, Joel A. Dave, Naomi S Levitt, Gary Maartens and David W. Haas

    Article first published online : 28 MAY 2015, DOI: 10.1111/bcp.12590

  4. Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 1, January 2008, Pages: 73–84, Mr Ping Liu, Dr Grover Foster, Mr Rober R. LaBadie, Dr Mari J. Gutierrez and Dr Amarnath Sharma

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007309703

  5. Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 3, March 2012, Pages: 475–482, V Michaud, E Ogburn, N Thong, A O Aregbe, T C Quigg, D A Flockhart and Z Desta

    Article first published online : 8 FEB 2012, DOI: 10.1038/clpt.2011.249

  6. You have free access to this content
    Biowaiver monographs for immediate release solid oral dosage forms: Efavirenz

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 2, February 2013, Pages: 318–329, Rodrigo Cristofoletti, Anita Nair, Bertil Abrahamsson, D. W. Groot, Sabine Kopp, Peter Langguth, James E. Polli, Vinod P. Shah and Jennifer B. Dressman

    Article first published online : 22 NOV 2012, DOI: 10.1002/jps.23380

  7. You have free access to this content
    Mitochondrial (dys)function – a factor underlying the variability of efavirenz-induced hepatotoxicity?

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1713–1727, M Polo, F Alegre, H A Funes, A Blas-Garcia, V M Victor, J V Esplugues and N Apostolova

    Article first published online : 8 JAN 2015, DOI: 10.1111/bph.13018

  8. You have free access to this content
    Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA

    HIV Medicine

    Volume 12, Issue 2, February 2011, Pages: 97–108, HE Hsu, CE Rydzak, KL Cotich, B Wang, PE Sax, E Losina, KA Freedberg, SJ Goldie, Z Lu, RP Walensky and for the CEPAC Investigators

    Article first published online : 17 JUN 2010, DOI: 10.1111/j.1468-1293.2010.00856.x

  9. You have full text access to this OnlineOpen article
    Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 4, October 2015, Pages: 406–416, L Dickinson, J Amin, L Else, M Boffito, D Egan, A Owen, S Khoo, D Back, C Orrell, A Clarke, M Losso, P Phanuphak, D Carey, DA Cooper, S Emery and R Puls2, on behalf of the ENCORE1 Study Group

    Article first published online : 14 JUL 2015, DOI: 10.1002/cpt.156

  10. Pharmacokinetic Interaction Between Efavirenz and Carbamazepine After Multiple-Dose Administration in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 8, August 2008, Pages: 948–956, Ping Ji, Dr Bharat Damle, Dr Jingdong Xie, Dr Steve E. Unger, Dennis M. Grasela and Sanjeev Kaul

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008319792

  11. Impact of Efavirenz on Intestinal Metabolism and Transport: Insights From an Interaction Study With Ezetimibe in Healthy Volunteers

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 3, March 2012, Pages: 506–513, S Oswald, H E Meyer zu Schwabedissen, A Nassif, C Modess, Z Desta, E T Ogburn, J Mostertz, M Keiser, J Jia, A Hubeny, A Ulrich, D Runge, M Marinova, D Lütjohann, H K Kroemer and W Siegmund

    Article first published online : 1 FEB 2012, DOI: 10.1038/clpt.2011.255

  12. You have free access to this content
    Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 997–1006, Daniel H. Johnson, Tebeb Gebretsadik, Ayumi Shintani, Gail Mayo, Edward P. Acosta, C. Michael Stein and David W. Haas

    Article first published online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04454.x

  13. Are Literature References Sufficient for Dose Recommendations? An FDA Case Study of Efavirenz and Rifampin

    The Journal of Clinical Pharmacology

    Volume 48, Issue 4, April 2008, Pages: 518–523, Dr Jennifer L. DiGiacinto, Dr Kirk M. Chan-Tack, Dr Sarah M. Robertson, Dr Kellie S. Reynolds and Dr Kimberly A. Struble

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008315308

  14. Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 1, July 2012, Pages: 103–111, H E Meyer zu Schwabedissen, S Oswald, C Bresser, A Nassif, C Modess, Z Desta, E T Ogburn, M Marinova, D Lütjohann, C Spielhagen, M Nauck, H K Kroemer and W Siegmund

    Article first published online : 16 MAY 2012, DOI: 10.1038/clpt.2012.34

  15. You have free access to this content
    Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 65, Issue 4, April 2008, Pages: 523–530, Bharat Damle, Robert LaBadie, Penelope Crownover and Paul Glue

    Article first published online : 20 FEB 2008, DOI: 10.1111/j.1365-2125.2007.03085.x

  16. A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens

    The Journal of Clinical Pharmacology

    Nontiya Homkham, Tim R. Cressey, Lily Ingsrisawang, Naïm Bouazza, Chaiwat Ngampiyaskul, Suchat Hongsiriwon, Sakulrat Srirojana, Suparat Kanjanavanit, Sorakij Bhakeecheep, Sophie Le Coeur, Nicolas Salvadori, Jean Marc Treluyer, Gonzague Jourdain and Saik Urien

    Article first published online : 24 FEB 2016, DOI: 10.1002/jcph.701

  17. Pharmacokinetics and Safety of the Lopinavir/Ritonavir Tablet 500/125 mg Twice Daily Coadministered With Efavirenz in Healthy Adult Participants

    The Journal of Clinical Pharmacology

    Volume 52, Issue 8, August 2012, Pages: 1248–1254, Juki Ng, Yi-Lin Chiu, Walid Awni, Barry Bernstein, Sonja J. Causemaker and Cheri E. Klein

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011410568

  18. Pharmacokinetics of Efavirenz When Co-administered With Rifampin in TB/HIV Co-infected Patients: Pharmacogenetic Effect of CYP2B6 Variation

    The Journal of Clinical Pharmacology

    Volume 48, Issue 9, September 2008, Pages: 1032–1040, Dr Awewura Kwara, Dr Margaret Lartey, Mr Kwamena W. Sagoe, Dr Fafa Xexemeku, Dr Ernest Kenu, Dr Joseph Oliver-Commey, Dr Vincent Boima, Mr Augustine Sagoe, Dr Isaac Boamah, Mr David J. Greenblatt and Dr Michael H. Court

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008321790

  19. You have free access to this content
    Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans

    HIV Medicine

    Volume 13, Issue 4, April 2012, Pages: 193–201, S Nanzigu, J Eriksen, F Makumbi, S Lanke, M Mahindi, R Kiguba, O Beck, Q Ma, GD Morse, LL Gustafsson and P Waako

    Article first published online : 22 NOV 2011, DOI: 10.1111/j.1468-1293.2011.00952.x

  20. A Study of the Binding Energies of Efavirenz to Wild-Type and K103N/Y181C HIV-1 Reverse Transcriptase Based on the ONIOM Method

    ChemMedChem

    Volume 3, Issue 5, May 19, 2008, Pages: 803–811, Pensri Srivab and Supa Hannongbua

    Article first published online : 12 MAR 2008, DOI: 10.1002/cmdc.200700181